Article ID Journal Published Year Pages File Type
3850344 American Journal of Kidney Diseases 2009 19 Pages PDF
Abstract
Currently, there are insufficient data to establish the comparative superiority of non-calcium-binding agents over calcium-containing phosphate binders for such important patient-level outcomes as all-cause mortality and cardiovascular end points. Additional trials are still required to examine the differential effects of phosphate-binding agents on these end points and the mineral homeostasis pathway.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , , , , , ,